Allen Capital Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Allen Capital Group's LLY Position: Q3 2026 in Review
Allen Capital Group increased its Eli Lilly (LLY) stake by 3.3% in Q3 2026, buying an estimated $82.6K and bringing the position to 2,172 shares worth $2.51M. The position accounts for 0.2% of the portfolio, ranked #100.
Allen Capital Group first reported a position in LLY in Q4 2021 and has held it in 13 quarters since. The position peaked at $2.52M in Q2 2026. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Allen Capital Group held 2,172 shares of Eli Lilly worth $2.51M as of Q3 2026.
- Allen Capital Group bought 70 Eli Lilly shares in Q3 2026, an estimated $82.6K.
- Eli Lilly made up 0.2% of Allen Capital Group's portfolio in Q3 2026, its #100 holding.
- Allen Capital Group first reported a position in Eli Lilly in Q4 2021 and has held it in 13 quarters since.
- Allen Capital Group's Eli Lilly position peaked at $2.52M in Q2 2026.
- 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Allen Capital Group's 13F filing for Q3 2026, filed 27 Oct 2026.